物質濫用
參考文獻

1 2 3   (PDF). UNITED NATIONS.   [2016-09-27]. （原始内容存档 (PDF)于2022-01-09）.
1 2  . emcdda.europa.eu.   [2016-09-27]. （原始内容存档于2019-07-17）.
1 2 3  GBD 2015 Mortality and Causes of Death, Collaborators. . Lancet. 2016-10-08, 388 (10053): 1459–1544. PMC 5388903 . PMID 27733281. doi:10.1016/S0140-6736(16)31012-1.
↑  Ksir, Oakley Ray; Charles.  9th. Boston [u.a.]: McGraw-Hill. 2002  [2021-06-02]. ISBN 978-0072319637. （原始内容存档于2021-12-22）.
↑  (2002). Mosby's Medical, Nursing & Allied Health Dictionary. Sixth Edition. Drug abuse definition, p. 552. Nursing diagnoses, p. 2109. ISBN 0-323-01430-5.
↑  .   [2014-07-02]. （原始内容存档于2014-06-24）.
↑  GBD 2013 Mortality and Causes of Death, Collaborators. . Lancet. 2014-12-17, 385 (9963): 117–71. PMC 4340604 . PMID 25530442. doi:10.1016/S0140-6736(14)61682-2.
↑   (PDF).   [2017-04-01]. （原始内容存档 (PDF)于2009-09-25）.
↑  Nutt, David J; King, Leslie A; Phillips, Lawrence D. . The Lancet. November 2010, 376 (9752): 1558–1565. CiteSeerX 10.1.1.690.1283 . PMID 21036393. S2CID 5667719. doi:10.1016/S0140-6736(10)61462-6.
↑  E. Fehrman, A. K. Muhammad, E. M. Mirkes, V. Egan, A. N. Gorban,The Five Factor Model of personality and evaluation of drug consumption risk （页面存档备份，存于）, arXiv:1506.06297 [stat.AP], 2015
↑  Philip Jenkins, Synthetic panics: the symbolic politics of designer drugs, NYU Press, 1999, ISBN 0-8147-4244-0, pp. ix–x
1 2  Fehrman, Elaine; Egan, Vincent; Gorban, Alexander N.; Levesley, Jeremy; Mirkes, Evgeny M.; Muhammad, Awaz K. . Springer, Cham. 2019. ISBN 978-3-030-10441-2. S2CID 151160405. arXiv:2001.06520 . doi:10.1007/978-3-030-10442-9.
↑  Barrett SP, Meisner JR, Stewart SH.  (PDF). Curr Drug Abuse Rev. November 2008, 1 (3): 255–62. PMID 19630724. doi:10.2174/1874473710801030255. （原始内容 (PDF)存档于2010-06-15）.
↑  McCabe SE, Boyd CJ, Teter CJ. . Drug Alcohol Depend. June 2009, 102 (1–3): 63–70. PMC 2975029 . PMID 19278795. doi:10.1016/j.drugalcdep.2009.01.007.
↑  Antai-Otong, D. 2008. Psychiatric Nursing: Biological and Behavioral Concepts. 2nd edition. Canada: Thompson Delmar Learning
↑  . PDMP Center of Excellence. 2010–2013  [2021-06-02]. （原始内容存档于2016-08-11）.
↑  "Topics in Brief: Prescription Drug Abuse" （页面存档备份，存于） NIDA, December 2011.
1 2 3  . National Institute on Drug Abuse. 2017-12-14  [2019-04-10]. （原始内容存档于2020-05-29） （英语）.
↑  .   [2021-06-02]. （原始内容存档于2021-12-22）.
↑  "Combating Prescription Drug Abuse in Your Practice" 的存檔，存档日期2012-06-18. Aubrey Westgate, Physicians Practice, June 2012.
1 2 3 4 5 6  D. Nutt（英语：）; King, L. A.; Saulsbury, W.; C. Blakemore. . The Lancet. 2007, 369 (9566): 1047–1053. PMID 17382831. S2CID 5903121. doi:10.1016/S0140-6736(07)60464-4.
↑  Burke PJ, O'Sullivan J, Vaughan BL. . Pediatr Emerg Care. November 2005, 21 (11): 770–6  [2021-06-02]. PMID 16280955. S2CID 36410538. doi:10.1097/01.pec.0000186435.66838.b3. （原始内容存档于2023-11-30）.
↑  Serafini G, Innamorati M, Dominici G, Ferracuti S, Kotzalidis GD, Serra G. . International Journal of Environmental Research and Public Health (International Journal Environmental Research and Public Health). April 2010, 7 (4): 1392–1431. PMC 2872355 . PMID 20617037. doi:10.3390/ijerph7041392.
↑  O'Connor, Rory; Sheehy, Noel. . Leicester: BPS Books. 2000-01-29: 33–36  [2021-06-02]. ISBN 978-1-85433-290-5. （原始内容存档于2021-12-22）.
↑  Isralowitz, Richard. . Santa Barbara, Calif.: ABC-CLIO. 2004: 122–123  [2021-06-02]. ISBN 978-1-57607-708-5. （原始内容存档于2021-12-22）.
↑  University of Miami: Substance Abuse, Substance Abuse and Health Risks
↑  Di Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, Bianconi F, Gardner-Sood P, O'Connor J, Russo M, Stilo SA, Marques TR, Mondelli V, Dazzan P, Pariante C, David AS, Gaughran F, Atakan Z, Iyegbe C, Powell J, Morgan C, Lynskey M, Murray RM.  (PDF). Lancet Psychiatry. 2015, 2 (3): 233–8  [2021-06-02]. PMID 26359901. doi:10.1016/S2215-0366(14)00117-5. （原始内容存档 (PDF)于2022-01-09）.
↑  Marta Di Forti. . Schizophrenia Bulletin. 2013-12-17, 40 (6): 1509–1517  [2021-06-02]. PMC 4193693 . PMID 24345517. doi:10.1093/schbul/sbt181. （原始内容存档于2016-10-12）.
↑  Evans, Katie; Sullivan, Michael J.  2nd. Guilford Press. 2001-03-01: 75–76  [2021-06-02]. ISBN 978-1-57230-446-8. （原始内容存档于2020-08-01）.
1 2  Hampton WH, Hanik I, Olson IR. . Drug and Alcohol Dependence. 2019, 197 (4): 288–298. PMC 6440853 . PMID 30875650. doi:10.1016/j.drugalcdep.2019.02.005 （英语）. Given that our the central nervous system is an intricately balanced, complex network of billions of neurons and supporting cells, some might imagine that extrinsic substances could cause irreversible brain damage. Our review paints a less gloomy picture of the substances reviewed, however. Following prolonged abstinence, abusers of alcohol (Pfefferbaum et al., 2014) or opiates (Wang et al., 2011) have white matter microstructure that is not significantly different from non-users. There was also no evidence that the white matter microstructural changes observed in longitudinal studies of cannabis, nicotine, or cocaine were completely irreparable. It is therefore possible that, at least to some degree, abstinence can reverse effects of substance abuse on white matter. The ability of white matter to “bounce back” very likely depends on the level and duration of abuse, as well as the substance being abused.
↑  . The Free Dictionary.   [2021-06-02]. （原始内容存档于2021-12-22）.
1 2  Gerard Moeller M.D., Barratt Ernest S., Ph, Dougherty Donald M., Ph, Schmitz Joy M., Ph, Swann Alan C. . The American Journal of Psychiatry. 2001, 158 (11): 1783–93. PMID 11691682. doi:10.1176/appi.ajp.158.11.1783. （原始内容存档于2013-04-15）.
↑  Bishara AJ, Pleskac TJ, Fridberg DJ, Yechiam E, Lucas J, Busemeyer JR, Finn PR, Stout JC. . J Behav Decis Mak. 2009, 22 (4): 435–454. PMC 3152830 . PMID 21836771. doi:10.1002/bdm.641.
↑  Kreek, Mary Jeanne; Nielsen, David A; Butelman, Eduardo R; LaForge, K Steven. . Nature Neuroscience. 2005-10-26, 8 (11): 1450–1457. PMID 16251987. S2CID 12589277. doi:10.1038/nn1583.
↑  Chambers RA, Taylor JR, Potenza MN. . Am J Psychiatry. 2003, 160 (6): 1041–52. PMC 2919168 . PMID 12777258. doi:10.1176/appi.ajp.160.6.1041.
↑  J Abnorml, Psychol. . NCBI Resources. 2011-08-22  [2020-12-16]. （原始内容存档于2021-12-22）.
↑  Jeronimus B.F.; Kotov, R.; Riese, H.; Ormel, J. . Psychological Medicine. 2016, 46 (14): 2883–2906  [2021-06-02]. PMID 27523506. doi:10.1017/S0033291716001653. （原始内容存档于2019-12-29）.
↑  Knight JR, Shrier LA, Harris SK, Chang G. . JAMA Pediatrics. 2002, 156 (6): 607–614  [2021-06-02]. doi:10.1001/archpedi.156.6.607. （原始内容存档于2021-12-22）.
↑  Dhalla S, Kopec JA. . Clinical and Investigative Medicine. 2007: 33–41  [2021-06-02]. doi:10.25011/cim.v30i1.447. （原始内容存档于2017-08-18）.
↑  Morse, Barbara.  (PDF). 1997: 4–5  [2021-06-02]. ISBN 978-1-57285-042-2. （原始内容存档 (PDF)于2021-12-07）.
↑  O'Donohue, W; K.E. Ferguson. . The Behavior Analyst Today. 2006, 7 (3): 335–350  [2008-03-24]. doi:10.1037/h0100155. （原始内容存档于2010-03-23）.
↑  Chambless, D.L.;  et al.  (PDF). Clinical Psychology. 1998, 49: 5–14  [2008-03-24]. （原始内容存档 (PDF)于2007-07-10）.
↑  . nihseniorhealth.gov.   [2015-07-29]. （原始内容存档于2015-08-11）.
↑  . （原始内容存档于2010-04-21）.
↑  . （原始内容存档于2010-06-13）.
1 2  Hogue, A; Henderson, CE; Ozechowski, TJ; Robbins, MS. . Journal of Clinical Child and Adolescent Psychology. 2014, 43 (5): 695–720. PMID 24926870. S2CID 10036629. doi:10.1080/15374416.2014.915550.
↑  . （原始内容存档于2010-04-21）.
↑  Engle, Bretton; Macgowan, Mark J. . Journal of Evidence-Based Social Work. 2009-08-05, 6 (3): 217–243. ISSN 1543-3714. PMID 20183675. S2CID 3293758. doi:10.1080/15433710802686971.
1 2  . crd.york.ac.uk.   [2016-03-09]. （原始内容存档于2021-05-10）.
↑  Carney, Tara; Myers, Bronwyn J; Louw, Johann; Okwundu, Charles I. . Cochrane Database of Systematic Reviews. 2016-01-20, (1): CD008969. PMC 7119449 . PMID 26787125. doi:10.1002/14651858.cd008969.pub3. hdl:10019.1/104381 .
↑  Jensen, Chad D.; Cushing, Christopher C.; Aylward, Brandon S.; Craig, James T.; Sorell, Danielle M.; Steele, Ric G. . Journal of Consulting and Clinical Psychology. 2011, 79 (4): 433–440. PMID 21728400. S2CID 19892519. doi:10.1037/a0023992.
↑  Barnett, Elizabeth; Sussman, Steve; Smith, Caitlin; Rohrbach, Louise A.; Spruijt-Metz, Donna. . Addictive Behaviors. 2012, 37 (12): 1325–1334. PMC 3496394 . PMID 22958865. doi:10.1016/j.addbeh.2012.07.001.
↑  .   [2015-05-27]. （原始内容存档于2015-05-21）.
↑  Uekermann J, Daum I. . Addiction. May 2008, 103 (5): 726–35. PMID 18412750. doi:10.1111/j.1360-0443.2008.02157.x.
↑  Purvis G.; MacInnis D. M.  (PDF). Journal of Behavior Analysis of Sports, Health, Fitness and Behavioral Medicine. 2009, 2: 133–44. （原始内容 (PDF)存档于2010-12-29）.
↑  . The California Evidence-Based Clearinghouse. 2006–2013  [2021-06-02]. （原始内容存档于2021-12-22）.
↑  James W. Kalat Biological psychology 11th edition pg.78
↑  Maglione, M; Maher, AR; Hu, J; Wang, Z; Shanman, R; Shekelle, PG; Roth, B; Hilton, L; Suttorp, MJ; Ewing, BA; Motala, A; Perry, T. . Agency for Healthcare Research and Quality (US). September 2011. PMID 22132426. Report No.: 11-EHC087-EF.
↑  Lingford-Hughes AR, Welch S, Peters L, Nutt DJ, ((British Association for Psychopharmacology, Expert Reviewers Group)). . Journal of Psychopharmacology. 2012-07-01, 26 (7): 899–952. ISSN 0269-8811. PMID 22628390. doi:10.1177/0269881112444324 .  温哥华格式错误 (帮助)
1 2  Lingford-Hughes A. R.; Welch S.; Peters L.; Nutt D. J.  (PDF). Journal of Psychopharmacology. 2012, 26 (7): 899–952. PMID 22628390. S2CID 30030790. doi:10.1177/0269881112444324. （原始内容 (PDF)存档于2012-12-03）.
1 2  Peterson Ashley L. . Issues in Mental Health Nursing. 2013, 34 (10): 752–756. PMID 24066651. S2CID 11537206. doi:10.3109/01612840.2013.809830.
1 2  Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2010 （页面存档备份，存于）. Ann Arbor: Institute for Social Research, The University of Michigan.
↑  .   [2021-06-02]. （原始内容存档于2021-12-07）.
↑  Barker, P. ed. 2003. Psychiatric and mental health nursing: the craft and caring. London: Arnold. pp297
↑  Effective Child Therapy: Substance Abuse and Dependence. Copyright 2012 的存檔，存档日期2013-05-03.
↑  "Drug Trade （页面存档备份，存于）". BBC News.
1 2 3 4  Overdose Death Rates （页面存档备份，存于）. By National Institute on Drug Abuse (NIDA).
↑   (PDF).   [2021-06-02]. （原始内容 (PDF)存档于2022-03-17）.
↑  Glasscote, R.M., Sussex, J.N., Jaffe, J.H., Ball, J., Brill, L. (1932). The Treatment of Drug Abuse for people like you...: Programs, Problems, Prospects. Washington, D.C.: Joint Information Service of the American Psychiatric Association and the National Association for Mental Health.
↑  . United States Commission on Marihuana and Drug Abuse. : 13  [2021-06-02]. ISBN 0-8422-7239-9. （原始内容存档于2021-12-22）.
↑  .   [2021-06-02]. （原始内容存档于2012-11-01）.
↑  DSM-IV & DSM-IV-TR:Substance Dependence 的存檔，存档日期2011-09-27.
↑  American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC.
↑  Hasin, Deborah S.; O’Brien, Charles P.; Auriacombe, Marc; Borges, Guilherme; Bucholz, Kathleen; Budney, Alan; Compton, Wilson M.; Crowley, Thomas; Ling, Walter. . American Journal of Psychiatry. 2013-08-01, 170 (8): 834–851. ISSN 0002-953X. PMC 3767415 . PMID 23903334. doi:10.1176/appi.ajp.2013.12060782.
↑  . Reference Reviews. 2014-03-11, 28 (3): 36–37. doi:10.1108/rr-10-2013-0256.
↑  Copeman M. . CMAJ. April 2003, 168 (9): 1113; author reply 1113. PMC 153673 . PMID 12719309. （原始内容存档于2009-09-06）.
↑  Wood E, Tyndall MW, Spittal PM,  et al. . CMAJ. January 2003, 168 (2): 165–9  [2021-06-02]. PMC 140425 . PMID 12538544. （原始内容存档于2024-03-11）.
↑  Bewley-Taylor, Dave, Hallam, Chris, Allen Rob. The Beckley Foundation Drug Policy Programme: The Incarceration of Drug Offenders: An Overview. March 2009.
1 2 3  Prieto L. . Substance Abuse Treatment, Prevention, and Policy. 2010, 5: 9. PMC 2881082 . PMID 20478069. doi:10.1186/1747-597x-5-9.
↑  . National Health Service (NHS). 2010-03-22  [2010-03-22]. （原始内容存档于2010-08-12）.
↑  . 2007-06-09  [2016-09-19]. （原始内容存档于2007-06-09）.
↑  Thornton, Mark. .   [2021-06-02]. （原始内容存档于2009-05-03）.
↑   (PDF).   [2021-06-02]. （原始内容存档 (PDF)于2016-03-24）.
↑  Owens PL, Barrett ML, Weiss AJ, Washington RE, Kronick R. . HCUP Statistical Brief #177. Rockville, MD: Agency for Healthcare Research and Quality. August 2014  [2021-06-02]. （原始内容存档于2019-09-03）.
↑  Drachman, D. . Social Work. 1992, 37 (1): 68–72. doi:10.1093/sw/37.1.68.
↑  Pumariega A. J.; Rothe E.; Pumariega J. B. . Community Mental Health Journal. 2005, 41 (5): 581–597. CiteSeerX 10.1.1.468.6034 . PMID 16142540. S2CID 7326036. doi:10.1007/s10597-005-6363-1.
1 2 3 4  National Institute on Alcohol Abuse and Alcoholism.  (2005).  Module 10F: Immigrants, refugees, and alcohol.  In NIAAA: Social work education for the prevention and treatment of alcohol use disorders (NIH publication).  Washington, D.C.
↑  Caetano R.; Clark C. L.; Tam T. . Journal of Alcohol, Health, and Research. 1998, 22 (4): 233–241.
↑  UNODC.  (PDF).   [2014-01-30]. （原始内容存档 (PDF)于2021-12-22）.
↑  Cottrell-Boyce, Joe.  (PDF). African Journal of Drug & Alcohol Studies. 2010, 9 (2): 93–102  [2014-01-28]. doi:10.4314/ajdas.v9i2.64142. （原始内容存档 (PDF)于2016-04-20）.
1 2 3 4  Breitenfeld D.; Thaller V.; Perić B.; Jagetic N.; Hadžić D.; Breitenfeld T. . Alcoholism: Journal on Alcoholism and Related Addictions. 2008, 44 (1): 37–42. ProQuest 622145760.
↑  Dunne, E. M., Burrell, L. I., Diggins, A. D., Whitehead, N. E., & Latimer, W. W. . The American Journal on Addictions. 2015, 24 (7): 676–680. PMC 6941432 . PMID 26359444. doi:10.1111/ajad.12289.
↑  Zlotnick, C., Tam, T., & Robertson, M. J. . Substance Use & Misuse. 2003, 38 (3–6): 577–599. PMID 12747398. S2CID 31815225. doi:10.1081/ja-120017386.
↑  . mentalhealth.va.gov.   [2016-12-17]. （原始内容存档于2021-10-04）.
1 2 3  McHugh, R. Kathryn; Votaw, Victoria R.; Sugarman, Dawn E.; Greenfield, Shelly F. . Clinical Psychology Review. Gender and Mental Health. 2018-12-01, 66: 12–23. ISSN 0272-7358. PMC 5945349 . PMID 29174306. doi:10.1016/j.cpr.2017.10.012.
1 2 3  Becker, Jill B.; McClellan, Michele L.; Reed, Beth Glover. . Journal of Neuroscience Research. 2016-11-07, 95 (1–2): 136–147. ISSN 0360-4012. PMC 5120656 . PMID 27870394. doi:10.1002/jnr.23963.
1 2 3  Walitzer, Kimberly S.; Dearing, Ronda L. . Clinical Psychology Review. Relapse in the addictive behaviors. 2006-03-01, 26 (2): 128–148. ISSN 0272-7358. PMID 16412541. doi:10.1016/j.cpr.2005.11.003.